Co-occurring pathogenic variants in 6q27 associated with dementia spectrum disorders in a Peruvian family.
Frontiers In Molecular Neuroscience
Alvarez, Karla Lucia F KLF; Aguilar-Pineda, Jorge Alberto JA; Ortiz-Manrique, Michelle M MM; Paredes-Calderon, Marluve F MF; Cardenas-Quispe, Bryan C BC; Vera-Lopez, Karin Jannet KJ; Goyzueta-Mamani, Luis D LD; Chavez-Fumagalli, Miguel Angel MA; Davila-Del-Carpio, Gonzalo G; Peralta-Mestas, Antero A; Musolino, Patricia L PL; Lino Cardenas, Christian Lacks CL
Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer's disease brain extracts.
Alzheimer'S Research & Therapy
Sandberg, Anders A; Berenjeno-Correa, Ernesto E; Rodriguez, Rosa Crespo RC; Axenhus, Michael M; Weiss, Sophia Schedin SS; Batenburg, Kevin K; Hoozemans, Jeroen J M JJM; Tjernberg, Lars O LO; Scheper, Wiep W
Aβ and tau prions feature in the neuropathogenesis of Down syndrome.
Proceedings Of The National Academy Of Sciences Of The United States Of America
Condello, Carlo C; Maxwell, Alison M AM; Castillo, Erika E; Aoyagi, Atsushi A; Graff, Caroline C; Ingelsson, Martin M; Lannfelt, Lars L; Bird, Thomas D TD; Keene, C Dirk CD; Seeley, William W WW; Perl, Daniel P DP; Head, Elizabeth E; Prusiner, Stanley B SB
Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer's disease brains.
Alzheimer'S & Dementia : The Journal Of The Alzheimer'S Association
Novotny, Brenna C BC; Fernandez, Maria Victoria MV; Wang, Ciyang C; Budde, John P JP; Bergmann, Kristy K; Eteleeb, Abdallah M AM; Bradley, Joseph J; Webster, Carol C; Ebl, Curtis C; Norton, Joanne J; Gentsch, Jen J; Dube, Umber U; Wang, Fengxian F; Morris, John C JC; Bateman, Randall J RJ; Perrin, Richard J RJ; McDade, Eric E; Xiong, Chengjie C; Chhatwal, Jasmeer J; , ; , ; , ; Goate, Alison A; Farlow, Martin M; Schofield, Peter P; Chui, Helena H; Karch, Celeste M CM; Cruchaga, Carlos C; Benitez, Bruno A BA; Harari, Oscar O
Exploring the Involvement of the Amyloid Precursor Protein A673T Mutation against Amyloid Pathology and Alzheimer's Disease in Relation to Therapeutic Editing Tools.
Pharmaceutics
Stanciu, Gabriela Dumitrita GD; Ababei, Daniela Carmen DC; Rusu, Razvan Nicolae RN; Bild, Veronica V; Tamba, Bogdan-Ionel BI
CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer's disease PSEN 1 M146L mutation.
Molecular Therapy. Nucleic Acids
Konstantinidis, Evangelos E; Molisak, Agnieszka A; Perrin, Florian F; Streubel-Gallasch, Linn L; Fayad, Sarah S; Kim, Daniel Y DY; Petri, Karl K; Aryee, Martin J MJ; Aguilar, Ximena X; György, Bence B; Giedraitis, Vilmantas V; Joung, J Keith JK; Pattanayak, Vikram V; Essand, Magnus M; Erlandsson, Anna A; Berezovska, Oksana O; Ingelsson, Martin M
Aβ profiles generated by Alzheimer's disease causing PSEN1 variants determine the pathogenicity of the mutation and predict age at disease onset.
Molecular Psychiatry
Petit, Dieter D; Fernández, Sara Gutiérrez SG; Zoltowska, Katarzyna Marta KM; Enzlein, Thomas T; Ryan, Natalie S NS; O'Connor, Antoinette A; Szaruga, Maria M; Hill, Elizabeth E; Vandenberghe, Rik R; Fox, Nick C NC; Chávez-Gutiérrez, Lucía L
Human iPSC-Derived Neural Models for Studying Alzheimer's Disease: from Neural Stem Cells to Cerebral Organoids.
Stem Cell Reviews And Reports
Barak, Martin M; Fedorova, Veronika V; Pospisilova, Veronika V; Raska, Jan J; Vochyanova, Simona S; Sedmik, Jiri J; Hribkova, Hana H; Klimova, Hana H; Vanova, Tereza T; Bohaciakova, Dasa D
Mitochondrial Ca2+ Signaling in Health, Disease and Therapy.
Cells
Modesti, Lorenzo L; Danese, Alberto A; Angela Maria Vitto, Veronica V; Ramaccini, Daniela D; Aguiari, Gianluca G; Gafà, Roberta R; Lanza, Giovanni G; Giorgi, Carlotta C; Pinton, Paolo P